Neutralizing antibodies are widely viewed as the frontline of antiviral defence. Yet emerging evidence reveals that T cells can terminate infection before it is detectable by routine clinical assays, independently of antibodies. Recognizing this capacity reframes correlates of protection and calls for vaccines that harness T cells as early, decisive defenders.

Abortive infection: T cells as early, antibody-independent defenders / Swadling, L., Fumagalli, V., Maini, M.K., Iannacone, M.. - In: NATURE REVIEWS IMMUNOLOGY. - ISSN 1474-1733. - 26:5(2026), pp. 327-329. [10.1038/s41577-026-01298-y]

Abortive infection: T cells as early, antibody-independent defenders

Fumagalli V.
Secondo
;
Iannacone M.
Ultimo
2026-01-01

Abstract

Neutralizing antibodies are widely viewed as the frontline of antiviral defence. Yet emerging evidence reveals that T cells can terminate infection before it is detectable by routine clinical assays, independently of antibodies. Recognizing this capacity reframes correlates of protection and calls for vaccines that harness T cells as early, decisive defenders.
File in questo prodotto:
File Dimensione Formato  
s41577-026-01298-y.pdf

solo gestori archivio

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Tutti i diritti riservati
Dimensione 1.12 MB
Formato Adobe PDF
1.12 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/205837
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact